Sandbox: malabsorption: Difference between revisions

Jump to navigation Jump to search
Line 289: Line 289:
*
*
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Ischemic colitis]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Ischemic colitis]]
Line 316: Line 318:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Mesenteric ischemia]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Mesenteric ischemia]]
Line 343: Line 347:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Lactose intolerance]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Lactose intolerance]]
Line 406: Line 412:
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*
*
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |  
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |  
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |  
* Diagnosis of exclusion
* Diagnosis of exclusion
Line 549: Line 556:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Pseudomembranous enterocolitis|Pseudomembranous colitis]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Pseudomembranous enterocolitis|Pseudomembranous colitis]]
Line 616: Line 625:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Salmonella]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Salmonella]]
Line 643: Line 654:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Campylobacter jejuni]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Campylobacter jejuni]]
Line 670: Line 683:
*
*
!
!
*
!
!
*
|-
|-
! rowspan="5" style="background:#DCDCDC;" align="center" |[[Escherichia coli|E-coli]]
! rowspan="5" style="background:#DCDCDC;" align="center" |[[Escherichia coli|E-coli]]
Line 698: Line 713:
*
*
!
!
*
!
!
*
|-
|-
| style="background:#DCDCDC;" align="center" |[[EPEC|'''EPEC''']]
| style="background:#DCDCDC;" align="center" |[[EPEC|'''EPEC''']]
Line 725: Line 742:
*
*
!
!
*
!
!
*
|-
|-
| style="background:#DCDCDC;" align="center" |[[EIEC|'''EIEC''']]
| style="background:#DCDCDC;" align="center" |[[EIEC|'''EIEC''']]
Line 752: Line 771:
*
*
!
!
*
!
!
*
|-
|-
| style="background:#DCDCDC;" align="center" |[[EHEC|'''EHEC''']]
| style="background:#DCDCDC;" align="center" |[[EHEC|'''EHEC''']]
Line 779: Line 800:
*
*
!
!
*
!
!
*
|-
|-
| style="background:#DCDCDC;" align="center" |[[EAEC|'''EAEC''']]
| style="background:#DCDCDC;" align="center" |[[EAEC|'''EAEC''']]
Line 806: Line 829:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Yersinia enterocolitica]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Yersinia enterocolitica]]
Line 833: Line 858:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Vibrio cholerae|Vibrio cholera]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Vibrio cholerae|Vibrio cholera]]
Line 860: Line 887:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Aeromonas]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Aeromonas]]
Line 887: Line 916:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Plesiomonas shigelloides|Plesiomonas]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Plesiomonas shigelloides|Plesiomonas]]
Line 914: Line 945:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Mycobacterium avium complex]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Mycobacterium avium complex]]
Line 941: Line 974:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |Other infections
! colspan="2" style="background:#DCDCDC;" align="center" |Other infections
Line 970: Line 1,005:
*
*
!
!
*
!
!
*
|-
|-
! rowspan="8" style="background:#4479BA; color: #FFFFFF;" align="center" |Virus
! rowspan="8" style="background:#4479BA; color: #FFFFFF;" align="center" |Virus
Line 998: Line 1,035:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Echovirus]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Echovirus]]
Line 1,025: Line 1,064:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Adenoviridae|Adenovirus]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Adenoviridae|Adenovirus]]
Line 1,052: Line 1,093:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Norovirus]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Norovirus]]
Line 1,079: Line 1,122:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[CMV colitis]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[CMV colitis]]
Line 1,106: Line 1,151:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Human Immunodeficiency Virus (HIV)|HIV]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Human Immunodeficiency Virus (HIV)|HIV]]
Line 1,133: Line 1,180:
*
*
!
!
*
!
!
*
|-
|-
! rowspan="2" style="background:#DCDCDC;" align="center" |[[Hepatitis]]
! rowspan="2" style="background:#DCDCDC;" align="center" |[[Hepatitis]]
Line 1,161: Line 1,210:
*
*
!
!
*
!
!
*
|-
|-
! style="background:#DCDCDC;" align="center" |[[Hepatitis E]]
! style="background:#DCDCDC;" align="center" |[[Hepatitis E]]
Line 1,188: Line 1,239:
*
*
!
!
*
!
!
*
|-
|-
! rowspan="6" style="background:#4479BA; color: #FFFFFF;" align="center" |Parasite
! rowspan="6" style="background:#4479BA; color: #FFFFFF;" align="center" |Parasite
Line 1,216: Line 1,269:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Giardia lamblia|Giardia]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Giardia lamblia|Giardia]]
Line 1,243: Line 1,298:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Cryptosporidium]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Cryptosporidium]]
Line 1,270: Line 1,327:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Microsporidia]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Microsporidia]]
Line 1,297: Line 1,356:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Isospora]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Isospora]]
Line 1,324: Line 1,385:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |Other Parasitic diarrhea
! colspan="2" style="background:#DCDCDC;" align="center" |Other Parasitic diarrhea
Line 1,353: Line 1,416:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" rowspan="6" style="background:#4479BA; color: #FFFFFF;" align="center" |Tumors
! colspan="2" rowspan="6" style="background:#4479BA; color: #FFFFFF;" align="center" |Tumors
Line 1,381: Line 1,446:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[VIPoma]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[VIPoma]]
Line 1,479: Line 1,546:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Lymphoma]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Lymphoma]]
Line 1,506: Line 1,575:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Colorectal cancer]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Colorectal cancer]]
Line 1,533: Line 1,604:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Medication/Toxicity
! colspan="2" rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Medication/Toxicity
Line 1,561: Line 1,634:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Laxative abuse]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Laxative abuse]]
Line 1,588: Line 1,663:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Heavy metal ingestion]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Heavy metal ingestion]]
Line 1,615: Line 1,692:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Organophosphate poisoning]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Organophosphate poisoning]]
Line 1,642: Line 1,721:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Opium withdrawal]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Opium withdrawal]]
Line 1,669: Line 1,750:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Iatrogenic
! colspan="2" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Iatrogenic
Line 1,709: Line 1,792:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* Surgical intestinal resection
* Surgical intestinal resection
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |  
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Radiation enteropathy|Radiation enteritis]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Radiation enteropathy|Radiation enteritis]]
Line 1,736: Line 1,820:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Gastric dumping syndrome|Dumping syndrome]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Gastric dumping syndrome|Dumping syndrome]]
Line 1,763: Line 1,849:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Others
! colspan="2" rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Others
Line 1,864: Line 1,952:
*
*
!
!
*
!
!
*
|-
|-
! colspan="2" style="background:#DCDCDC;" align="center" |[[Scleroderma|Systemic sclerosis]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Scleroderma|Systemic sclerosis]]
Line 1,891: Line 1,981:
*
*
!
!
*
!
!
*
|- }
|- }
|}
|}

Revision as of 17:24, 12 December 2017

Diarrhea

Abbreviations: GI: Gastrointestinal, WBC: White blood cells, Plt: Platelets, Hgb: Hemoglobin, IgE: Immunoglobulin E, IgA: Immunoglobulin A, ETEC: Escherichia coli enteritis, EPEC: Enteropathogenic Escherichia coli, EIEC: Enteroinvasive Escherichia coli, EHEC: Enterohemorrhagic Escherichia coli, EAEC: Enteroaggregative Escherichia coli

Categories Cause Clinical manifestation Lab findings Extra intestinal findings Cause/Pathogenesis Gold standard diagnosis
Symptoms GI signs
Duration Diarrhea Fever Abdominal pain Weight loss
Stool exam CBC Other lab findings
Acute Chronic Watery Bloody Fatty WBC RBC Ova/Parasite Osmotic gap Other WBC Hgb Plt
Gastrointestinal Crohns disease - + + + + ± + + + + - -
  • Abnormal immune response to self antigens
Ulcerative colitis - + + + + + + + -
  • Hypoalbuminemia
  • Hypokalemia
  • Hypomagnesemia
  • Iron deficiency
  • Elevated ESR
  • Elevated CRP
  • Abnormal immune response to self antigens
Celiac disease - + ± - ± - + +
- -
  • IgA endomysial antibody
  • Anti-tissue transglutaminase antibody
  • Anti-gliadin antibody
  • IgA endomysial antibody
  • IgA tissue transglutaminase antibody
Cystic fibrosis - + - - + ± + +
- -
  • Positive DNA analysis for CFTR
  • Evaluated nasal transepithelial potential difference (NPD)
Chronic pancreatitis - + + - + - + +
- - -
  • Slightly elevated amylase and lipase
  • Abnormal pancreatic function test
  • Repeated acute pancreatitis
  • Alcohol abuse
  • Genetic
  • Autoimmune
Microscopic colitis - + + + - - + + -
- -
Infective colitis
Ischemic colitis
Mesenteric ischemia
Lactose intolerance + + + - - - + -
- - -
Irritable bowel syndrome - + ± - ± - ± - -
- - -
  • Diagnosis of exclusion
Infection Bacterial Whipple's disease - + + - + ± + + - - - ↓/↑
Tropical sprue + + + - + + + +
- -
  • Diagnosis of exclusion
Small bowel bacterial overgrowth - + + - + - + +
- -
  • Excess bacteria in the small intestine
  • Alterations in intestinal anatomy or GI motility, 
  • Lack of gastric acid secretion
  • Diagnosis of exclusion
Food poisoning
Pseudomembranous colitis + - + +/- - + + +/-
  • Abdominal tenderness
  • Presence of pseudomembranes of endoscopy
  • Enzyme immunoassay (EIA) for C difficile toxin A and B
  • Polymerase chain reaction (PCR) assay or C difficile antigen (glutamate dehydrogenase [GDH]) EIA
  • Leukocytosis
  • Elevated serum creatinine
  • Hypoalbuminemia
  • Anasarca
  • Elevated serum lactate
  • Recent antibiotics use
  • Recent surgery
  • Colon cancer
  • Diverticulitis
  • Appendicitis
  • Stool exam
  • CT
Shigella
Salmonella
Campylobacter jejuni
E-coli ETEC + -
EPEC
EIEC
EHEC
EAEC
Yersinia enterocolitica
Vibrio cholera
Aeromonas
Plesiomonas
Mycobacterium avium complex + + +/- + -
+/- + - -
- -
  • Immune system analysis may show defects
Other infections
  • aaaa
  • bbbb
+ + - + +/-
+ + - -
  • Stool culture may be positive for responsible organism
- -
Virus Rotavirus
Echovirus
Adenovirus
Norovirus
CMV colitis + + +/- + -
+/- + - -
- -
  • CD 4 level decreased as it is maily associated with HIV
HIV
Hepatitis Hepatitis A
Hepatitis E
Parasite Entamoeba histolytica
Giardia
Cryptosporidium
Microsporidia
Isospora + + + -
+ + - -
-
Other Parasitic diarrhea
  • aaaa
  • bbbb
+ + + - + +/-
+ + + -
- -
Tumors Carcinoid tumor
VIPoma + + + - + - + +
- - -
  • Primary secretory tumor
  • Elevated VIP levels
  • Followed by imaging
Zollinger-Ellison syndrome - + + - + - + +
- -
  • Elevated basal or stimulated serum gastrin> 120 pg/mL
Somatostatinoma
Lymphoma
Colorectal cancer + + + +
- + - -
- ↑/↓ -
  • May be associated with FAP gene or HNPCC gene
Medication/Toxicity Drug induced enteritis
Laxative abuse
Heavy metal ingestion
Organophosphate poisoning
Opium withdrawal
Iatrogenic Short bowel syndrome + + + - + - - +
-
  • Prior intestinal surgery
  • Surgical intestinal resection
Radiation enteritis
Dumping syndrome
Others Abetalipoproteinemia - + + - + - + +
- - -
Hyperthyroidism - + + - - ± + +
- - -
  • Elevated T4
  • Elevated T3
  • Decreased TSH
Diabetic neuropathy
Systemic sclerosis